Eloxx Pharmaceuticals, Inc. (ELOX)
13.56
+0.22
(+1.65%)
USD |
OTCM |
Oct 28, 11:15
Eloxx Pharmaceuticals Cash from Operations (Quarterly) : -4.789M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.789M |
| March 31, 2026 | -5.453M |
| June 30, 2025 | |
| September 30, 2023 | -3.45M |
| June 30, 2023 | -2.066M |
| March 31, 2023 | -6.814M |
| December 31, 2022 | -5.661M |
| September 30, 2022 | -6.946M |
| June 30, 2022 | -9.747M |
| March 31, 2022 | -9.491M |
| December 31, 2021 | -9.931M |
| September 30, 2021 | -7.588M |
| June 30, 2021 | -9.797M |
| March 31, 2021 | -7.685M |
| December 31, 2020 | -4.668M |
| September 30, 2020 | -5.258M |
| June 30, 2020 | -6.316M |
| March 31, 2020 | -11.92M |
| December 31, 2019 | -9.257M |
| September 30, 2019 | -11.32M |
| June 30, 2019 | -9.624M |
| March 31, 2019 | -9.188M |
| December 31, 2018 | -9.06M |
| September 30, 2018 | -8.099M |
| June 30, 2018 | -8.511M |
| Date | Value |
|---|---|
| March 31, 2018 | -5.697M |
| June 30, 2017 | -0.5088M |
| March 31, 2017 | -0.4047M |
| December 31, 2016 | -0.4379M |
| September 30, 2016 | -0.5737M |
| June 30, 2016 | -0.7148M |
| March 31, 2016 | -0.841M |
| December 31, 2015 | -0.9883M |
| September 30, 2015 | -1.132M |
| June 30, 2015 | -2.466M |
| March 31, 2015 | -1.406M |
| December 31, 2014 | -1.533M |
| September 30, 2014 | -1.939M |
| June 30, 2014 | -1.218M |
| March 31, 2014 | -1.558M |
| December 31, 2013 | -1.422M |
| September 30, 2013 | -0.6705M |
| June 30, 2013 | -0.9463M |
| March 31, 2013 | -1.754M |
| December 31, 2012 | -0.5654M |
| September 30, 2012 | -0.6365M |
| June 30, 2012 | -1.108M |
| March 31, 2012 | -0.98M |
| December 31, 2011 | -1.208M |
| September 30, 2011 | -1.090M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | -3.855M |
| CorMedix, Inc. | 86.06M |
| Breakthrough Chemistry, Inc. | -0.0073M |
| BioStem Technologies, Inc. | -5.538M |
| Cardiac Biotech Solutions, Inc. | -0.1918M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 60.39M |
| Free Cash Flow Per Share (Quarterly) | -0.7054 |
| Free Cash Flow to Equity (Quarterly) | -4.789M |
| Free Cash Flow to Firm (Quarterly) | -4.781M |
| Free Cash Flow Yield | -37.20% |